Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

IGFBP6 controls the expansion of chemoresistant glioblastoma through paracrine IGF2/IGF-1R signaling.

Oliva CR, Halloran B, Hjelmeland AB, Vazquez A, Bailey SM, Sarkaria JN, Griguer CE.

Cell Commun Signal. 2018 Sep 19;16(1):61. doi: 10.1186/s12964-018-0273-7.

2.

Whole-Genome Multi-omic Study of Survival in Patients with Glioblastoma Multiforme.

Bernal Rubio YL, González-Reymúndez A, Wu KH, Griguer CE, Steibel JP, de Los Campos G, Doseff A, Gallo K, Vazquez AI.

G3 (Bethesda). 2018 Nov 6;8(11):3627-3636. doi: 10.1534/g3.118.200391.

3.

Cytochrome C oxidase Inhibition and Cold Plasma-derived Oxidants Synergize in Melanoma Cell Death Induction.

Gandhirajan RK, Rödder K, Bodnar Y, Pasqual-Melo G, Emmert S, Griguer CE, Weltmann KD, Bekeschus S.

Sci Rep. 2018 Aug 24;8(1):12734. doi: 10.1038/s41598-018-31031-2.

4.

Repositioning chlorpromazine for treating chemoresistant glioma through the inhibition of cytochrome c oxidase bearing the COX4-1 regulatory subunit.

Oliva CR, Zhang W, Langford C, Suto MJ, Griguer CE.

Oncotarget. 2017 Jun 6;8(23):37568-37583. doi: 10.18632/oncotarget.17247.

5.

The methyl donor S-adenosylmethionine prevents liver hypoxia and dysregulation of mitochondrial bioenergetic function in a rat model of alcohol-induced fatty liver disease.

King AL, Mantena SK, Andringa KK, Millender-Swain T, Dunham-Snary KJ, Oliva CR, Griguer CE, Bailey SM.

Redox Biol. 2016 Oct;9:188-197. doi: 10.1016/j.redox.2016.08.005. Epub 2016 Aug 17.

6.

Identification of Small Molecule Inhibitors of Human Cytochrome c Oxidase That Target Chemoresistant Glioma Cells.

Oliva CR, Markert T, Ross LJ, White EL, Rasmussen L, Zhang W, Everts M, Moellering DR, Bailey SM, Suto MJ, Griguer CE.

J Biol Chem. 2016 Nov 11;291(46):24188-24199. Epub 2016 Sep 27.

7.
8.

Involvement of the mitochondrial permeability transition pore in chronic ethanol-mediated liver injury in mice.

King AL, Swain TM, Mao Z, Udoh US, Oliva CR, Betancourt AM, Griguer CE, Crowe DR, Lesort M, Bailey SM.

Am J Physiol Gastrointest Liver Physiol. 2014 Feb 15;306(4):G265-77. doi: 10.1152/ajpgi.00278.2013. Epub 2013 Dec 19.

9.

Mitochondrial bioenergetics of metastatic breast cancer cells in response to dynamic changes in oxygen tension: effects of HIF-1α.

Diers AR, Vayalil PK, Oliva CR, Griguer CE, Darley-Usmar V, Hurst DR, Welch DR, Landar A.

PLoS One. 2013 Jun 28;8(6):e68348. doi: 10.1371/journal.pone.0068348. Print 2013.

10.

Prognostic relevance of cytochrome C oxidase in primary glioblastoma multiforme.

Griguer CE, Cantor AB, Fathallah-Shaykh HM, Gillespie GY, Gordon AS, Markert JM, Radovanovic I, Clement-Schatlo V, Shannon CN, Oliva CR.

PLoS One. 2013 Apr 10;8(4):e61035. doi: 10.1371/journal.pone.0061035. Print 2013.

11.

Acquisition of chemoresistance in gliomas is associated with increased mitochondrial coupling and decreased ROS production.

Oliva CR, Moellering DR, Gillespie GY, Griguer CE.

PLoS One. 2011;6(9):e24665. doi: 10.1371/journal.pone.0024665. Epub 2011 Sep 9.

12.

Bioenergetics pathways and therapeutic resistance in gliomas: emerging role of mitochondria.

Griguer CE, Oliva CR.

Curr Pharm Des. 2011;17(23):2421-7. Review.

PMID:
21827418
13.

Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chain.

Oliva CR, Nozell SE, Diers A, McClugage SG 3rd, Sarkaria JN, Markert JM, Darley-Usmar VM, Bailey SM, Gillespie GY, Landar A, Griguer CE.

J Biol Chem. 2010 Dec 17;285(51):39759-67. doi: 10.1074/jbc.M110.147504. Epub 2010 Sep 24.

14.

CD133 is a marker of bioenergetic stress in human glioma.

Griguer CE, Oliva CR, Gobin E, Marcorelles P, Benos DJ, Lancaster JR Jr, Gillespie GY.

PLoS One. 2008;3(11):e3655. doi: 10.1371/journal.pone.0003655. Epub 2008 Nov 5.

15.

The integrin Mac-1 (CR3) mediates internalization and directs Bacillus anthracis spores into professional phagocytes.

Oliva CR, Swiecki MK, Griguer CE, Lisanby MW, Bullard DC, Turnbough CL Jr, Kearney JF.

Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1261-6. doi: 10.1073/pnas.0709321105. Epub 2008 Jan 23.

16.

Pharmacologic manipulations of mitochondrial membrane potential (DeltaPsim) selectively in glioma cells.

Griguer CE, Oliva CR, Gillespie GY, Gobin E, Marcorelles P, Yancey Gillespie G.

J Neurooncol. 2007 Jan;81(1):9-20. Epub 2006 Jul 22.

PMID:
16862448
17.

Xanthine oxidase-dependent regulation of hypoxia-inducible factor in cancer cells.

Griguer CE, Oliva CR, Kelley EE, Giles GI, Lancaster JR Jr, Gillespie GY.

Cancer Res. 2006 Feb 15;66(4):2257-63.

18.

Glucose metabolism heterogeneity in human and mouse malignant glioma cell lines.

Griguer CE, Oliva CR, Gillespie GY.

J Neurooncol. 2005 Sep;74(2):123-33.

PMID:
16193382

Supplemental Content

Loading ...
Support Center